Tag
2 articles
Learn to analyze microbiome data using Python to identify potential therapeutic targets for cancer immunotherapy, similar to what mbiomics is developing for advanced melanoma treatment.
German biotech Kupando has raised €10M to advance its innate immunity drug KUP101 into human clinical trials, targeting solid tumors and drug-resistant infections.
